46K
Downloads
56
Episodes
A podcast about the people behind world-leading research at University Health Network, Canada's largest research hospital.
Episodes
Monday Nov 21, 2022
Monday Nov 21, 2022
Dr. Lorraine Kalia’s research looks at testing different compounds in C. Elegans and how it can lead to a better understanding of Parkinson’s disease and new therapeutic targets. The best part: some of these compounds are already approved for use in humans. Through Dr. Kalia’s research we may be able to repurpose these compounds for the neurodegenerative condition.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.